COVID-19 drug lead treatments identified
An international team of researchers has tested more than 10,000 compounds to identify six drug candidates that may help treat COVID-19.
“Currently there are no targeted therapeutics or effective treatment options for COVID-19,” Professor Guddat said.
“In order to rapidly discover lead compounds for clinical use, we initiated a program of high-throughput drug screening, both in laboratories and also using the latest computer software to predict how different drugs bind to the virus.
Professor Guddat said the project targeted the main COVID-19 virus enzyme, known as the main protease or Mpro, which plays a pivotal role in mediating viral replication.
“This makes it an attractive drug target for this virus, and as people don’t naturally have this enzyme, compounds that target it are likely to have low toxicity.
“We add the drugs directly to the enzyme or to cell cultures growing the virus and assess how much of each compound is required to stop the enzyme from working or to kill the virus.
“If the amount is small, then we have a promising compound for further studies.”
After assaying thousands of drugs, researchers found of the six that appear to be effective in inhibiting the enzyme, one is of particular interest.
“We’re particularly looking at several leads that have been subjected to clinical trials including for the prevention and treatment of various disorders such as cardiovascular diseases, arthritis, stroke, atherosclerosis and cancer,” Professor Guddat said.
“Compounds that are already along the pipeline to drug discovery are preferred, as they can be further tested as antivirals at an accelerated rate compared to new drug leads that would have to go through this process from scratch.”
After the enzyme’s structure was made public, the team received more than 300 requests for more information, even before the paper was published.
“To provide an analogy, we’ve provided scientists with a fishing pole, the line and the exact bait, and have in only one month caught some fish,” Professor Guddat said.
“Now it’s up to us and the other fisherman – our fellow scientists globally – to take full advantage of this breakthrough.”
“With continued and up-scaled efforts we are optimistic that new candidates can enter the COVID-19 drug discovery pipeline in the near future.”
The international collaboration was led by researchers at ShanghaiTech University.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- New Progress in Study on Mechanism of Lianhua Qingwen Capsules for Treatment of COVID-19on February 23, 2021 at 1:05 am
Yifeng Chai from the School of Pharmacy, Xiamen University have made new progress in the study of the pharmacologically active ingredients and mechanism of Lianhua Qingwen Capsules, developed and ...
- Argentina publishes the VIP list, who received preferential Covid 19 vaccine treatmenton February 23, 2021 at 1:04 am
The Argentine government has published a list of 70 influential figures, mostly politicians and close friends and family members, who have received preferential vaccine Covid 19 treatment, at the ...
- Animal Doctor: Veterinarian disciplined for advocating COVID-19 treatmenton February 23, 2021 at 1:00 am
Dr. Margo Roman of Massachusetts has had an attack on her state license for advocating medical ozone therapy as a protocol for disinfection of PPE and as a ...
- 7 Fibromyalgia Experts Discuss the Covid-19 Vaccineon February 23, 2021 at 12:45 am
Should you get a Covid-19 vaccination if you have fibromyalgia? That's the question many fibromyalgia patients are asking. Are people with fibromyalgia at increased risk if they get Covid? Are there ...
- Missouri has 1 confirmed case of a COVID-19 variant, but wastewater testing tells a different storyon February 23, 2021 at 12:11 am
Genetic material from COVID-19 can be present in human waste even when the person has no symptoms. A project tracking the variants found it throughout the state ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- US deaths account for 20% of world's total of 2.4M; Johnson & Johnson plans 20M vaccine doses by end of March. Latest COVID-19 updateson February 23, 2021 at 1:01 am
The White House said this weekend that despite the drop in cases this month, life won't return to normal for quite some time. Latest virus updates.
- 'We've done worse than most any other country,' Fauci says as US marks grim Covid-19 death tollon February 23, 2021 at 12:30 am
The US has now surpassed the devastating milestone of half a million Covid-19 deaths. It's a staggering figure that experts say did not have to be this high.
- A Biden edge in COVID-19 bill: Dems reluctant to wound himon February 23, 2021 at 12:28 am
Democrats have a potent dynamic on their side as Congress preps for its first votes on the party’s $1.9 trillion COVID-19 relief bill ...
- US Covid-19 deaths pass 500,000on February 23, 2021 at 12:00 am
A nightmare of this magnitude seemed unfathomable just a year ago. Half a million US lives have been lost to Covid-19, more than the number of Americans killed in World War II.
- Chicago White Sox manager Tony La Russa, 76, received the COVID-19 vaccine before the start of spring trainingon February 22, 2021 at 11:18 pm
Chicago White Sox manager Tony La Russa said he received the COVID-19 vaccine. And speaking generally about following the health and safety protocols as a team, he added, "It’s something that will be ...